Ivey Business School (Canada)
-
Measuring Impairment at Dofasco
Mary Gillett; Mary-Jane MastrandreaCase IVEY-9B09B017-EAccounting and ControlIn December 2008, the ArcelorMittal Dofasco (Dofasco) accounting team was facing a significant challenge. In the past few years, Dofasco had undergone significant ownership changes, and when the firm had first been acquired the market had placed a premium share value on the Dofasco subsidiary. In light of a recent economic downturn, the accounting team was required to reassess the values assigned to the subsidiary's net assets. Dismal forecasted ...Starting at €8.20
-
Scenic Floral Inc.: Growing a Start-Up
Susan J. Van Weelden; Laurie George Busuttil; Emma Vander PloegCase IVEY-9B21M015-EStrategyIn May 2020, Scenic Floral Inc. (Scenic), a Beamsville, Ontario start-up that sourced fresh cut flowers from Colombian farms and the Niagara Peninsula, was aggressively looking to expand the business. The company’s Mother’s Day sales had started out very slowly in 2020 as the floral industry in Canada and worldwide began to recover from the coronavirus (COVID-19) pandemic. While a flurry of last-minute orders from Scenic’s two largest customers m...Starting at €8.20
-
Nuway Software: Making the New Way Sustainable
Susan J. Van Weelden; Laurie George BusuttilCase IVEY-9B20M104-EStrategyNuway Software (Nuway) specialized in custom mobile software. While it had procured many contracts over its 15 year history, mostly for the less than truckload and courier sectors of the transportation industry, by the beginning of 2020, it had not foundStarting at €8.20
-
Accounting at Biovail - Revised
Mary Gillett; Mary-Jane Mastrandrea; Jessica FrischCase IVEY-9B09B004-EAccounting and ControlBiovail was a large international pharmaceutical company with reported revenues of $788 million. Banc of America has issued a research report which indicates that Biovail Corporation's financial statements raised a number of issues that warrant caution for investors, and as a result, Biovail's stock was given a sell rating by Banc of America. A member of Biovail's audit committee is preparing for an upcoming audit meeting and considers the implic...Starting at €8.20